Nuclear Medicine Radiopharmaceuticals-Global Market Status and Trend Report 2013-2023
Report Summary
Nuclear Medicine Radiopharmaceuticals-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Nuclear Medicine Radiopharmaceuticals industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Global Nuclear Medicine Radiopharmaceuticals Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Nuclear Medicine Radiopharmaceuticals Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic
Brachytherapy
Other Therapeutic
Global Nuclear Medicine Radiopharmaceuticals Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Thyroid
Cardiology
Others
Global Nuclear Medicine Radiopharmaceuticals Market: Manufacturers Segment Analysis (Company and Product introduction, Nuclear Medicine Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin):
Mallinckrodt
Isorad
Cardinal Health
Jubilant
Medi-Radiopharma
Comecer
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Nuclear Medicine Radiopharmaceuticals-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Nuclear Medicine Radiopharmaceuticals industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
- Worldwide and Regional Market Size of Nuclear Medicine Radiopharmaceuticals 2013-2017, and development forecast 2018-2023
- Main manufacturers/suppliers of Nuclear Medicine Radiopharmaceuticals worldwide, with company and product introduction, position in the Nuclear Medicine Radiopharmaceuticals market
- Market status and development trend of Nuclear Medicine Radiopharmaceuticals by types and applications
- Cost and profit status of Nuclear Medicine Radiopharmaceuticals, and marketing status
- Market growth drivers and challenges
Global Nuclear Medicine Radiopharmaceuticals Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Nuclear Medicine Radiopharmaceuticals Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic
Brachytherapy
Other Therapeutic
Global Nuclear Medicine Radiopharmaceuticals Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Thyroid
Cardiology
Others
Global Nuclear Medicine Radiopharmaceuticals Market: Manufacturers Segment Analysis (Company and Product introduction, Nuclear Medicine Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin):
Mallinckrodt
Isorad
Cardinal Health
Jubilant
Medi-Radiopharma
Comecer
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
1.1 Definition of Nuclear Medicine Radiopharmaceuticals in This Report
1.2 Commercial Types of Nuclear Medicine Radiopharmaceuticals
1.2.1 Diagnostic
1.2.2 Brachytherapy
1.2.3 Other Therapeutic
1.3 Downstream Application of Nuclear Medicine Radiopharmaceuticals
1.3.1 Oncology
1.3.2 Thyroid
1.3.3 Cardiology
1.3.4 Others
1.4 Development History of Nuclear Medicine Radiopharmaceuticals
1.5 Market Status and Trend of Nuclear Medicine Radiopharmaceuticals 2013-2023
1.5.1 Global Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Nuclear Medicine Radiopharmaceuticals 2013-2017
2.2 Production Market of Nuclear Medicine Radiopharmaceuticals by Regions
2.2.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Regions
2.2.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Regions
2.3 Demand Market of Nuclear Medicine Radiopharmaceuticals by Regions
2.4 Production and Demand Status of Nuclear Medicine Radiopharmaceuticals by Regions
2.4.1 Production and Demand Status of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
2.4.2 Import and Export Status of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Types
3.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Types
3.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry
4.2 Market Forecast of Nuclear Medicine Radiopharmaceuticals by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
5.1 Global Economy Situation and Trend Overview
5.2 Nuclear Medicine Radiopharmaceuticals Downstream Industry Situation and Trend Overview
CHAPTER 6 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers
6.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers
6.3 Basic Information of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Manufacturer
6.3.2 Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Mallinckrodt
7.1.1 Company profile
7.1.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.1.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt
7.2 Isorad
7.2.1 Company profile
7.2.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.2.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad
7.3 Cardinal Health
7.3.1 Company profile
7.3.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.3.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health
7.4 Jubilant
7.4.1 Company profile
7.4.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.4.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant
7.5 Medi-Radiopharma
7.5.1 Company profile
7.5.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.5.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma
7.6 Comecer
7.6.1 Company profile
7.6.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.6.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer
7.7 Jaco
7.7.1 Company profile
7.7.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.7.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco
7.8 Ciaeriar
7.8.1 Company profile
7.8.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.8.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar
7.9 Advanced Molecular-imaging Solution
7.9.1 Company profile
7.9.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.9.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
8.1 Industry Chain of Nuclear Medicine Radiopharmaceuticals
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
9.1 Cost Structure Analysis of Nuclear Medicine Radiopharmaceuticals
9.2 Raw Materials Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.3 Labor Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.4 Manufacturing Expenses Analysis of Nuclear Medicine Radiopharmaceuticals
CHAPTER 10 MARKETING STATUS ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Nuclear Medicine Radiopharmaceuticals in This Report
1.2 Commercial Types of Nuclear Medicine Radiopharmaceuticals
1.2.1 Diagnostic
1.2.2 Brachytherapy
1.2.3 Other Therapeutic
1.3 Downstream Application of Nuclear Medicine Radiopharmaceuticals
1.3.1 Oncology
1.3.2 Thyroid
1.3.3 Cardiology
1.3.4 Others
1.4 Development History of Nuclear Medicine Radiopharmaceuticals
1.5 Market Status and Trend of Nuclear Medicine Radiopharmaceuticals 2013-2023
1.5.1 Global Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Nuclear Medicine Radiopharmaceuticals 2013-2017
2.2 Production Market of Nuclear Medicine Radiopharmaceuticals by Regions
2.2.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Regions
2.2.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Regions
2.3 Demand Market of Nuclear Medicine Radiopharmaceuticals by Regions
2.4 Production and Demand Status of Nuclear Medicine Radiopharmaceuticals by Regions
2.4.1 Production and Demand Status of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
2.4.2 Import and Export Status of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Types
3.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Types
3.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry
4.2 Market Forecast of Nuclear Medicine Radiopharmaceuticals by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
5.1 Global Economy Situation and Trend Overview
5.2 Nuclear Medicine Radiopharmaceuticals Downstream Industry Situation and Trend Overview
CHAPTER 6 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers
6.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers
6.3 Basic Information of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Manufacturer
6.3.2 Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Mallinckrodt
7.1.1 Company profile
7.1.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.1.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt
7.2 Isorad
7.2.1 Company profile
7.2.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.2.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad
7.3 Cardinal Health
7.3.1 Company profile
7.3.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.3.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health
7.4 Jubilant
7.4.1 Company profile
7.4.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.4.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant
7.5 Medi-Radiopharma
7.5.1 Company profile
7.5.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.5.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma
7.6 Comecer
7.6.1 Company profile
7.6.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.6.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer
7.7 Jaco
7.7.1 Company profile
7.7.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.7.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco
7.8 Ciaeriar
7.8.1 Company profile
7.8.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.8.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar
7.9 Advanced Molecular-imaging Solution
7.9.1 Company profile
7.9.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.9.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
8.1 Industry Chain of Nuclear Medicine Radiopharmaceuticals
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
9.1 Cost Structure Analysis of Nuclear Medicine Radiopharmaceuticals
9.2 Raw Materials Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.3 Labor Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.4 Manufacturing Expenses Analysis of Nuclear Medicine Radiopharmaceuticals
CHAPTER 10 MARKETING STATUS ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
